BAXTER INTERNATIONAL INC (BAX) Fundamental Analysis & Valuation

NYSE:BAX • US0718131099

Current stock price

17.58 USD
+0.68 (+4.02%)
At close:
17.5803 USD
0 (0%)
After Hours:

This BAX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BAX Profitability Analysis

1.1 Basic Checks

  • BAX had positive earnings in the past year.
  • In the past year BAX had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: BAX reported negative net income in multiple years.
  • In the past 5 years BAX always reported a positive cash flow from operatings.
BAX Yearly Net Income VS EBIT VS OCF VS FCFBAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B

1.2 Ratios

  • BAX has a better Return On Assets (-4.77%) than 68.45% of its industry peers.
  • Looking at the Return On Equity, with a value of -15.61%, BAX is in the better half of the industry, outperforming 63.10% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 1.97%, BAX is doing good in the industry, outperforming 69.52% of the companies in the same industry.
  • BAX had an Average Return On Invested Capital over the past 3 years of 3.01%. This is significantly below the industry average of 9.14%.
Industry RankSector Rank
ROA -4.77%
ROE -15.61%
ROIC 1.97%
ROA(3y)0.7%
ROA(5y)-0.53%
ROE(3y)2.23%
ROE(5y)-4.18%
ROIC(3y)3.01%
ROIC(5y)3.68%
BAX Yearly ROA, ROE, ROICBAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

1.3 Margins

  • Looking at the Operating Margin, with a value of 3.78%, BAX is in the better half of the industry, outperforming 70.05% of the companies in the same industry.
  • BAX's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 30.68%, BAX is not doing good in the industry: 73.80% of the companies in the same industry are doing better.
  • BAX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.78%
PM (TTM) N/A
GM 30.68%
OM growth 3Y-22.24%
OM growth 5Y-24.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.08%
GM growth 5Y-5.03%
BAX Yearly Profit, Operating, Gross MarginsBAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. BAX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BAX is destroying value.
  • The number of shares outstanding for BAX has been increased compared to 1 year ago.
  • The number of shares outstanding for BAX has been increased compared to 5 years ago.
  • Compared to 1 year ago, BAX has an improved debt to assets ratio.
BAX Yearly Shares OutstandingBAX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
BAX Yearly Total Debt VS Total AssetsBAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • BAX has an Altman-Z score of 2.20. This is not the best score and indicates that BAX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • BAX has a better Altman-Z score (2.20) than 62.03% of its industry peers.
  • The Debt to FCF ratio of BAX is 28.54, which is on the high side as it means it would take BAX, 28.54 years of fcf income to pay off all of its debts.
  • BAX's Debt to FCF ratio of 28.54 is fine compared to the rest of the industry. BAX outperforms 66.84% of its industry peers.
  • BAX has a Debt/Equity ratio of 1.55. This is a high value indicating a heavy dependency on external financing.
  • BAX has a Debt to Equity ratio of 1.55. This is amonst the worse of the industry: BAX underperforms 81.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF 28.54
Altman-Z 2.2
ROIC/WACC0.35
WACC5.61%
BAX Yearly LT Debt VS Equity VS FCFBAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 2.31 indicates that BAX has no problem at all paying its short term obligations.
  • The Current ratio of BAX (2.31) is comparable to the rest of the industry.
  • A Quick Ratio of 1.56 indicates that BAX should not have too much problems paying its short term obligations.
  • BAX has a worse Quick ratio (1.56) than 60.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.56
BAX Yearly Current Assets VS Current LiabilitesBAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. BAX Growth Analysis

3.1 Past

  • The earnings per share for BAX have decreased strongly by -16.24% in the last year.
  • The Earnings Per Share has been decreasing by -5.98% on average over the past years.
  • BAX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.54%.
  • The Revenue has been decreasing by -0.75% on average over the past years.
EPS 1Y (TTM)-16.24%
EPS 3Y-13.44%
EPS 5Y-5.98%
EPS Q2Q%-24.14%
Revenue 1Y (TTM)-12.54%
Revenue growth 3Y-9.39%
Revenue growth 5Y-0.75%
Sales Q2Q%8.03%

3.2 Future

  • BAX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.25% yearly.
  • The Revenue is expected to grow by 3.37% on average over the next years.
EPS Next Y-14.55%
EPS Next 2Y-4.68%
EPS Next 3Y0.24%
EPS Next 5Y8.25%
Revenue Next Year2.42%
Revenue Next 2Y2.32%
Revenue Next 3Y2.41%
Revenue Next 5Y3.37%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BAX Yearly Revenue VS EstimatesBAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
BAX Yearly EPS VS EstimatesBAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

6

4. BAX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 7.74, which indicates a rather cheap valuation of BAX.
  • Based on the Price/Earnings ratio, BAX is valued cheaply inside the industry as 94.65% of the companies are valued more expensively.
  • BAX is valuated cheaply when we compare the Price/Earnings ratio to 26.77, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 9.06, which indicates a very decent valuation of BAX.
  • 95.72% of the companies in the same industry are more expensive than BAX, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of BAX to the average of the S&P500 Index (21.75), we can say BAX is valued rather cheaply.
Industry RankSector Rank
PE 7.74
Fwd PE 9.06
BAX Price Earnings VS Forward Price EarningsBAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BAX indicates a rather cheap valuation: BAX is cheaper than 87.17% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, BAX is valued a bit cheaper than the industry average as 79.68% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 27.34
EV/EBITDA 11.55
BAX Per share dataBAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.68%
EPS Next 3Y0.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. BAX Dividend Analysis

5.1 Amount

  • BAX has a yearly dividend return of 0.22%, which is pretty low.
  • BAX's Dividend Yield is rather good when compared to the industry average which is at 0.25. BAX pays more dividend than 89.30% of the companies in the same industry.
  • With a Dividend Yield of 0.22, BAX pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.22%

5.2 History

  • The dividend of BAX decreases each year by -6.21%.
  • BAX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-6.21%
Div Incr Years0
Div Non Decr Years0
BAX Yearly Dividends per shareBAX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • BAX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-36.36%
EPS Next 2Y-4.68%
EPS Next 3Y0.24%
BAX Yearly Income VS Free CF VS DividendBAX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B

More info and screens

Find the best dividend stocksShow peers with best dividend

BAX Fundamentals: All Metrics, Ratios and Statistics

BAXTER INTERNATIONAL INC

NYSE:BAX (4/30/2026, 8:04:00 PM)

After market: 17.5803 0 (0%)

17.58

+0.68 (+4.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength11.18
Industry Growth60.87
Earnings (Last)04-30
Earnings (Next)N/A
Inst Owners109.33%
Inst Owner Change-3.82%
Ins Owners0.18%
Ins Owner Change7.47%
Market Cap9.08B
Revenue(TTM)11.24B
Net Income(TTM)-957.00M
Analysts64.55
Price Target21.88 (24.46%)
Short Float %7.33%
Short Ratio4.18
Dividend
Industry RankSector Rank
Dividend Yield 0.22%
Yearly Dividend0.68
Dividend Growth(5Y)-6.21%
DP-36.36%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.28%
Min EPS beat(2)-18.72%
Max EPS beat(2)14.16%
EPS beat(4)2
Avg EPS beat(4)0.98%
Min EPS beat(4)-18.72%
Max EPS beat(4)14.16%
EPS beat(8)6
Avg EPS beat(8)3.02%
EPS beat(12)9
Avg EPS beat(12)2.81%
EPS beat(16)10
Avg EPS beat(16)2.49%
Revenue beat(2)1
Avg Revenue beat(2)0.95%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)4.28%
Revenue beat(4)2
Avg Revenue beat(4)0.23%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)4.28%
Revenue beat(8)5
Avg Revenue beat(8)0.31%
Revenue beat(12)7
Avg Revenue beat(12)0.01%
Revenue beat(16)7
Avg Revenue beat(16)-1.2%
PT rev (1m)-1.48%
PT rev (3m)-7.82%
EPS NQ rev (1m)0.83%
EPS NQ rev (3m)-34.84%
EPS NY rev (1m)0.1%
EPS NY rev (3m)-14.54%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-0.86%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.45%
Valuation
Industry RankSector Rank
PE 7.74
Fwd PE 9.06
P/S 0.81
P/FCF 27.34
P/OCF 10.74
P/B 1.48
P/tB N/A
EV/EBITDA 11.55
EPS(TTM)2.27
EY12.91%
EPS(NY)1.94
Fwd EY11.03%
FCF(TTM)0.64
FCFY3.66%
OCF(TTM)1.64
OCFY9.31%
SpS21.78
BVpS11.87
TBVpS-6.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number24.6246 (40.07%)
Profitability
Industry RankSector Rank
ROA -4.77%
ROE -15.61%
ROCE 2.49%
ROIC 1.97%
ROICexc 2.22%
ROICexgc 5.77%
OM 3.78%
PM (TTM) N/A
GM 30.68%
FCFM 2.95%
ROA(3y)0.7%
ROA(5y)-0.53%
ROE(3y)2.23%
ROE(5y)-4.18%
ROIC(3y)3.01%
ROIC(5y)3.68%
ROICexc(3y)3.41%
ROICexc(5y)4.11%
ROICexgc(3y)9.09%
ROICexgc(5y)11.24%
ROCE(3y)3.97%
ROCE(5y)4.78%
ROICexgc growth 3Y-20.11%
ROICexgc growth 5Y-19.9%
ROICexc growth 3Y-20.01%
ROICexc growth 5Y-27.24%
OM growth 3Y-22.24%
OM growth 5Y-24.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.08%
GM growth 5Y-5.03%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF 28.54
Debt/EBITDA 6.74
Cap/Depr 52.29%
Cap/Sales 4.56%
Interest Coverage 1.4
Cash Conversion 60.1%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.56
Altman-Z 2.2
F-Score4
WACC5.61%
ROIC/WACC0.35
Cap/Depr(3y)50.61%
Cap/Depr(5y)56.74%
Cap/Sales(3y)5.15%
Cap/Sales(5y)5.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.24%
EPS 3Y-13.44%
EPS 5Y-5.98%
EPS Q2Q%-24.14%
EPS Next Y-14.55%
EPS Next 2Y-4.68%
EPS Next 3Y0.24%
EPS Next 5Y8.25%
Revenue 1Y (TTM)-12.54%
Revenue growth 3Y-9.39%
Revenue growth 5Y-0.75%
Sales Q2Q%8.03%
Revenue Next Year2.42%
Revenue Next 2Y2.32%
Revenue Next 3Y2.41%
Revenue Next 5Y3.37%
EBIT growth 1Y-55.07%
EBIT growth 3Y-29.54%
EBIT growth 5Y-24.96%
EBIT Next Year37.67%
EBIT Next 3Y12.11%
EBIT Next 5Y14.25%
FCF growth 1Y-42.06%
FCF growth 3Y-14.54%
FCF growth 5Y-22.12%
OCF growth 1Y-17.08%
OCF growth 3Y-11.3%
OCF growth 5Y-14.67%

BAXTER INTERNATIONAL INC / BAX Fundamental Analysis FAQ

What is the fundamental rating for BAX stock?

ChartMill assigns a fundamental rating of 4 / 10 to BAX.


Can you provide the valuation status for BAXTER INTERNATIONAL INC?

ChartMill assigns a valuation rating of 6 / 10 to BAXTER INTERNATIONAL INC (BAX). This can be considered as Fairly Valued.


How profitable is BAXTER INTERNATIONAL INC (BAX) stock?

BAXTER INTERNATIONAL INC (BAX) has a profitability rating of 4 / 10.


What is the valuation of BAXTER INTERNATIONAL INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BAXTER INTERNATIONAL INC (BAX) is 7.74 and the Price/Book (PB) ratio is 1.48.


How financially healthy is BAXTER INTERNATIONAL INC?

The financial health rating of BAXTER INTERNATIONAL INC (BAX) is 4 / 10.